These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 8952766)

  • 1. Questions-answers about antiphospholipid-protein antibodies and the "antiphospholipid antibody syndrome".
    Boffa MC; Piette JC
    Ann Med Interne (Paris); 1996 Sep; 147 Suppl 1():54-6. PubMed ID: 8952766
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombosis in the antiphospholipid-antibody syndrome.
    Violi F; Ferro D; Valesini G
    N Engl J Med; 1995 Sep; 333(10):665; author reply 666-7. PubMed ID: 7637735
    [No Abstract]   [Full Text] [Related]  

  • 3. Need for additional trials of primary prophylaxis in patients with high-risk antiphospholipid antibody profiles: comment on the article by Erkan et al.
    Wahl D; Lecompte T; Bounameaux H
    Arthritis Rheum; 2008 Feb; 58(2):635-6; author reply 636. PubMed ID: 18240250
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study.
    Ruffatti A; Del Ross T; Ciprian M; Bertero MT; Sciascia S; Scarpato S; Montecucco C; Rossi S; Caramaschi P; Biasi D; Doria A; Rampudda M; Monica N; Fischetti F; Picillo U; Brucato A; Salvan E; Vittorio P; Meroni P; Tincani A;
    Ann Rheum Dis; 2011 Jun; 70(6):1083-6. PubMed ID: 21285115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Suspension of anticoagulation in patients with primary antiphospholipid syndrome in which a negative antibody antiphospholipid].
    Rodríguez-Fernández S; Saavedra Ramírez P; Espinosa Garriga G; Cervera Segura R
    Rev Clin Esp; 2009; 209(7):357-8. PubMed ID: 19709543
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiphospholipid syndrome.
    Nelson GN
    J Hand Surg Am; 2010 Nov; 35(11):1890-2; quiz 1892. PubMed ID: 20870361
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment.
    Asherson RA; Cervera R; Merrill JT; Erkan D
    Semin Thromb Hemost; 2008 Apr; 34(3):256-66. PubMed ID: 18720305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical approach to antiphospholipid syndrome: from facts to questions].
    Piette JC; Wechsler B; Blétry O; Frances C
    Presse Med; 1992 Dec; 21(43):2081-4. PubMed ID: 1297117
    [No Abstract]   [Full Text] [Related]  

  • 9. Venous thrombosis in the antiphospholipid syndrome.
    Farmer-Boatwright MK; Roubey RA
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):321-5. PubMed ID: 19228605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiphospholipid syndrome and stroke].
    Kitagawa Y
    Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relapsing splenic vein thrombosis associated with antiphospholipid antibodies in a patient with wegener granulomatosis.
    Steen KS; Peters MJ; Zweegman S; de Groot PG; Voskuyl AE
    J Clin Rheumatol; 2007 Apr; 13(2):92-3. PubMed ID: 17414539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the antiphospholipid syndrome and its treatment.
    Arnout J; Jankowski M
    Curr Hematol Rep; 2005 Sep; 4(5):385-90. PubMed ID: 16131440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiphospholipid antibody syndrome: implications for nursing practice.
    Brenner ZR; Myer SA
    Heart Lung; 2000; 29(5):331-9. PubMed ID: 10986527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiphospholipid syndrome nephropathy in antiphospholipid antibody-positive patients with systemic lupus erythematosus: comment on the article by Tektonidou et al.
    Korkmaz C
    Arthritis Rheum; 2005 Mar; 52(3):988-9; author reply 989-90. PubMed ID: 15751054
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals.
    Girón-González JA; García del Río E; Rodríguez C; Rodríguez-Martorell J; Serrano A
    J Rheumatol; 2004 Aug; 31(8):1560-7. PubMed ID: 15290736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphospholipid antibodies and antiphospholipid syndrome in patients with malignancies: features, incidence, identification, and treatment.
    Miesbach W
    Semin Thromb Hemost; 2008 Apr; 34(3):282-5. PubMed ID: 18720308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on antiphospholipid syndrome.
    Lockshin MD
    Bull NYU Hosp Jt Dis; 2008; 66(3):195-7. PubMed ID: 18937631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapeutic strategies in antiphospholipid syndrome.
    Hoi AY; Ross L; Day J; Buchanan RR
    Intern Med J; 2017 Mar; 47(3):250-256. PubMed ID: 27572264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. beta 2 Glycoprotein I--a key player in the antiphospholipid syndrome.
    Lutters BC; de Groot PG; Derksen RH
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):958-62. PubMed ID: 12455190
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk of thrombosis in patients with antiphospholipid antibodies and factor V Leiden mutation.
    Pablos JL; Caliz RA; Carreira PE; Atsumi T; Serrano L; Amengual O; Santiago B; Khamashta MA; Hughes GR; Gomez-Reino JJ
    J Rheumatol; 1999 Mar; 26(3):588-90. PubMed ID: 10090167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.